Detalles de la búsqueda
1.
Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study.
Epilepsia
; 64(1): 139-151, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36196777
2.
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trial.
Epilepsia
; 64(10): 2653-2666, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37543865
3.
Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopment.
Epilepsy Behav
; 138: 108994, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36463826
4.
Considerations for determining the efficacy of new antiseizure medications in children age 1 month to younger than 2 years.
Epilepsia
; 63(10): 2664-2670, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35835554
5.
Fenfluramine modulates the anti-amnesic effects induced by sigma-1 receptor agonists and neuro(active)steroids in vivo.
Epilepsy Behav
; 127: 108526, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35007961
6.
Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children/young adults with Dravet syndrome.
Epilepsy Behav
; 121(Pt A): 108024, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34023810
7.
Treatment with fenfluramine in patients with Dravet syndrome has no long-term effects on weight and growth.
Epilepsy Behav
; 122: 108212, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34352670
8.
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial.
Lancet
; 394(10216): 2243-2254, 2019 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31862249
9.
Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long-term open-label safety extension study.
Epilepsia
; 61(11): 2386-2395, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32809271
10.
Fenfluramine HCl (Fintepla® ) provides long-term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open-label extension study.
Epilepsia
; 61(11): 2396-2404, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33078386
11.
Fenfluramine acts as a positive modulator of sigma-1 receptors.
Epilepsy Behav
; 105: 106989, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32169824
12.
A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a regimen of stiripentol, clobazam, and valproate in healthy subjectsâ©.
Int J Clin Pharmacol Ther
; 57(1): 11-19, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30336805
13.
Long-term cardiovascular safety of fenfluramine in patients with Dravet syndrome treated for up to 3 years: Findings from serial echocardiographic assessments.
Eur J Paediatr Neurol
; 39: 35-39, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35640431
14.
Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial.
JAMA Neurol
; 79(6): 554-564, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35499850
15.
Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial.
JAMA Neurol
; 77(3): 300-308, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31790543
16.
A randomized controlled trial of ganaxolone in posttraumatic stress disorder.
Psychopharmacology (Berl)
; 234(15): 2245-2257, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28667510
17.
Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting.
J Clin Psychiatry
; 68(5): 711-20, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17503980
18.
Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.
J Clin Psychiatry
; 67(10): 1624-32, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17107257
Resultados
1 -
18
de 18
1
Próxima >
>>